Latest Northpond Ventures, LLC Stock Portfolio
Northpond Ventures, LLC Performance:
2024 Q3: -2.09%YTD: 12.97%2023: -70.02%
Performance for 2024 Q3 is -2.09%, and YTD is 12.97%, and 2023 is -70.02%.
About Northpond Ventures, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Northpond Ventures, LLC reported an equity portfolio of $43.7 Millions as of 30 Sep, 2024.
The top stock holdings of Northpond Ventures, LLC are , VIGL, CADL. The fund has invested 36.5% of it's portfolio in KYVERNA THERAPEUTICS INC and 32.8% of portfolio in VIGIL NEUROSCIENCE INC.
The fund managers got completely rid off TELESIS BIO INC (DNAY) stocks.
The top stock holdings of Northpond Ventures, LLC are , VIGL, CADL. The fund has invested 36.5% of it's portfolio in KYVERNA THERAPEUTICS INC and 32.8% of portfolio in VIGIL NEUROSCIENCE INC.
The fund managers got completely rid off TELESIS BIO INC (DNAY) stocks.
Northpond Ventures, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Northpond Ventures, LLC made a return of -2.09% in the last quarter. In trailing 12 months, it's portfolio return was -31.64%.
New Buys
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| telesis bio inc | -1,996,170 |
Northpond Ventures, LLC got rid off the above stocks
Sector Distribution
Northpond Ventures, LLC has about 63.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 63.5 |
| Others | 36.5 |
Market Cap. Distribution
Northpond Ventures, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MICRO-CAP | 63.5 |
| UNALLOCATED | 36.5 |
Stocks belong to which Index?
About 32.8% of the stocks held by Northpond Ventures, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 67.2 |
| RUSSELL 2000 | 32.8 |
Northpond Ventures, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Northpond Ventures, LLC
Northpond Ventures, LLC has 3 stocks in it's portfolio. VIGL proved to be the most loss making stock for the portfolio. CADL was the most profitable stock for Northpond Ventures, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| kyverna therapeutics inc | 36.46 | 3,255,430 | 15,919,000 | unchanged | 0.00 | |||
| VIGL | vigil neuroscience inc | 32.82 | 4,214,500 | 14,329,300 | unchanged | 0.00 | ||
| CADL | candel therapeutics inc | 30.72 | 1,935,220 | 13,411,000 | unchanged | 0.00 | ||
| DNAY | telesis bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
